BiotechTube

dirucotide + placebo

Phase 2/3Completed
0 watching 0 views this week📈 Rising
65
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Relapsing Remitting Multiple Sclerosis

Conditions

Relapsing Remitting Multiple Sclerosis

Trial Timeline

Nov 1, 2006 → Sep 1, 2009

NCT ID
NCT00869986

About dirucotide + placebo

dirucotide + placebo is a phase 2/3 stage product being developed by Eli Lilly for Relapsing Remitting Multiple Sclerosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00869986. Target conditions include Relapsing Remitting Multiple Sclerosis.

Hype Score Breakdown

Clinical
22
Activity
15
Company
10
Novelty
7
Community
8

Clinical Trials (2)

NCT IDPhaseStatus
NCT00869986Phase 2/3Completed
NCT00869726Phase 2/3Completed

Competing Products

20 competing products in Relapsing Remitting Multiple Sclerosis

See all competitors
ProductCompanyStageHype Score
Placebo + PirtobrutinibEli LillyPhase 2
52
CT-P53 + US-Ocrevus + EU-OcrevusCelltrionPhase 3
77
LY2127399 + PlaceboEli LillyPhase 2
52
BIIB019 (Daclizumab High Yield Process) + PlaceboAbbViePhase 2
52
DaclizumabAbbViePhase 3
77
BIIB019 (Daclizumab High Yield Process) + PlaceboAbbViePhase 2
52
BIIB019 (Daclizumab) + trivalent seasonal influenza vaccineAbbViePhase 2
52
BIIB019 (Daclizumab)AbbViePhase 3
77
BIIB019 (Daclizumab High Yield Process) + Interferon beta-1a Placebo + Interferon beta-1a + Daclizumab High Yield Process PlaceboAbbViePhase 3
77
Rebif (Interferon beta-1a)MerckPre-clinical
23
Interferon beta-1aMerckPre-clinical
23
Rebif New Formulation + prophylactic Ibuprofen + Rebif New Formulation + ibuprofen PRNMerckPhase 3
77
Rebif® + Avonex®MerckPhase 3
77
Rebif® + Rebif®MerckApproved
85
VigantOL oil plus interferon beta-1a (Rebif) + Placebo plus interferon beta-1a (Rebif) + Interferon beta-1a (Rebif®) aloneMerckPhase 2
52
Placebo + IFN beta-1a + MethylprednisoloneMerckPhase 2
52
Interferon beta-1a (Rebif)MerckApproved
85
Teriflunomide + EvobrutinibMerckPhase 3
77
Cladribine + Placebo + Microgynon®MerckPhase 1
33
Rebif (Interferon beta-1a)MerckPre-clinical
23

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved
85
Olanzapine + PlaceboApproved
85
exenatide and sitagliptin + exenatide and placeboApproved
85
Tirzepatide + PlaceboApproved
85
tadalafilApproved
85